
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes

Tuesday Apr 12, 2022
AAAAI 2022: Improving outcomes for patients with eosinophilic esophagitis
Tuesday Apr 12, 2022
Tuesday Apr 12, 2022
touchCONGRESS for touchRESPIRATORY
Listen to Dr Evan Dellon (USA) cover key data presented at AAAAI 2022 Annual Meeting on eosinophilic esophagitis (EoE) including risk factors and pathogenesis, burden of disease and emerging treatment options, as well as expert insights and interpretation from Dr Stuart Carr (Abu Dhabi, UAE) and Dr Alexandra Papadopoulou (Greece).
Overview
- Data review with Dr Evan Dellon (00:55)
- Expert interview with Dr Evan Dellon, Dr Stuart Carr and Dr Alexandra Papadopoulou (37:05)
Interview questions
- How do the latest data improve our understanding of the pathogenesis of EoE and what are the implications for practice? (37:40)
- How do the latest data on overlapping atopic conditions in patients with EoE correspond to the patients you manage? (42:23)
- What are the clinical implications of the data presented from the three-part, phase III trial evaluating dupilumab in patients with EoE? (48:12)
- Are the presented data on the use of single or multiple biologics in patients with overlapping atopic conditions encouraging? (53:18)
- What is your key takeaway from AAAAI 2022? (58:27)
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is provided by touchIME.
For further information visit our website: https://touchrespiratoryime.org/eoe-aaaai-2022/
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.